Venture Capital News | Private Equity News
Summary
Closes $12.1M Series B-1 Financing, Readies Limited Market Release of its VisionPort System For Minimally Invasive SurgeryBOSTON, November 21, 2022-- New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), today announced the closure of a $12.1M Series B-1 equity financing round to fund the commercialization of its VisionPort System. In emerging markets, the VisionPort System will greatly reduce the capital-intensive equipment currently required to perform minimally invasive surgery, and thus, make state-of-the-art technology more accessible. The VisionPort System is intended to be used in a broad range of diagnostic and therapeutic procedures within the thoracic and abdominal cavities and is adaptable to a wide variety of surgical environments, representing a significant market opportunity. The funds raised in this Series B-1 round came exclusively from our current investors, a testament to our companys accomplishments to date and vision for how we can positively impact the minimally invasive surgery space in the future. The VisionPort System is unique in that it provides surgeons with novel viewpoints of the operative field, workflow efficiencies for staff, reduced risks to the patient, and lower costs for the facility.